A pilot study of ADRA2A genotype association with doses of dexmedetomidine for sedation in pediatric patients.

Gallaway, Katherine A; Skaar, Todd C; Biju, Ashwin; Slaven, James; Tillman, Emma M

Gallaway, Katherine A; Skaar, Todd C; Biju, Ashwin; Slaven, James; Tillman, Emma M.

Affiliation

Gallaway KA; Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Skaar TC; Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Biju A; Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Slaven J; Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Tillman EM; Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Pharmacotherapy ; 42(6): 453-459, 2022 06.

Article in En | MEDLINE | ID: mdl-35429176

Subject(s)

Dexmedetomidine; Receptors, Adrenergic, alpha-2; Adult; Child; Dexmedetomidine/administration & dosage; Genotype; Humans; Hypnotics and Sedatives/administration & dosage; Intensive Care Units; Pilot Projects; Receptors, Adrenergic, alpha-2/genetics

Key words

adrenergic; alpha-2; child; dexmedetomidine; pharmacogenetics; receptor

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Adrenergic, alpha-2 / Dexmedetomidine Type of study: Risk_factors_studies Limits: Adult / Child / Humans Language: En Journal: Pharmacotherapy Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google